Mid-Day Update: Stocks Lower; Earnings, GDP Data Disappoint

By
A A A

Here's where markets stand at mid-day:

-NYSE down 51.51 (-0.64%) to 8,002.38

-DJIA down 84.28 (-0.7%) to 11,965.72

-S&P 500 down 9.73 (-0.75%) to 1,273.81

-Nasdaq down 21.74 (-0.81%) to 2,665.03

GLOBAL SENTIMENT

Nikkei up 0.9%.

Hang Seng up 1.9%.

Shanghai Composite up 2.2%.

FTSE-100 up 0.9%.

MID-DAY NYSE INDEX WATCH

NYSE Energy down 0.85% at 12,832.44

NYSE Financial down 0.85% at 4,717.27

NYSE Health Care down 1.18% at 7,110.05

NYSE Arca Tech 100 down 0.87% at 1,128.61

UPSIDE MOVERS

(+) SUG (+16.9%) continues evening gain that followed Williams' $39 per-share offer.

(+) SSN (+5.2%) buying additional Bakken acreage.

(+) CMCSA (+0.02%) upgraded.

(+) DO (+0.8%) upgraded.

(+) KOG (+0.7%) upgraded.

(+) BBBB (+6.5%) reportedly in talks to be bought.

(+) TIF (+0.6%) downgraded.

DOWNSIDE MOVERS

(-) PTIE (-39.7%) along with PFE and DRRX get complete response letter on Remoxy.

(-) DRRX (-32.0%) along with PFE and PTIE get complete response letter on Remoxy.

(-) AEGR (-4.1%) prices shares.

(-) IRE (-2.6%) may raise money in swap.

(-) LUX (-1.5%) downgraded.

(-) MU (-12.7%) misses with earnings.

(-) ORCL (-3.4%) beats with earnings but guides in line and key sales figures disappoint.

MARKET DIRECTION

Stocks are lower for the second session in a row after new data showed the US economy grew slower than analysts had expected, and reports from two tech names failed to inspire investor confidence.

The U.S. economy grew at a slightly faster 1.9% clip in Q1 compared to 1.8% revealed in the initial reading, although a touch shy of Wall Street expectations for a revised 2%. In Europe, just as progress on Greek aid cheered investors, a suspension in Italian banking share trade rattled markets anew.

Trading in Italian bank stocks was suspended Friday after a sudden drop in share prices, MarketWatch reports. A spokeswoman for Borsa Italiana said the suspension was temporary and was triggered by "technical problems about volatility."

In earnings, Oracle (ORCL) is down after the company reported a rise in fiscal Q4 profit that topped analyst expectations. However, traders look to be focusing on the report's details. Hardware sales dropped during the quarter in contrast to Oracle's previous forecast of a rise of up to 12%.

On its conference call, ORCL said it expects Q1 revenue growth in the range of of 9% to 12%. Non-GAAP EPS is seen in the range of $0.45 to $0.48 per share. The Street is at 9% revenue growth and earnings of $0.46 per share. Earlier, the company reported Q4 revenue of $10.77 bln, just ahead of the analyst consensus of $10.74 bln on Thomson Reuters. EPS $0.75, vs. expectations of $0.71 per share.

Also, Micron (MU) is lower after it reports late Thursday Q3 sales of $2.13 billion, below the analyst consensus of $2.36 billion on Thomson Reuters. EPS was $0.07 per share, vs. expectations of $0.16 per share.

Elsewhere in company news:

NYSE Euronext (NYX) and Deutsche Boerse AG will pay $910 million in dividends to shareholders to settle lawsuits challenging the $9.53 billion buyout of the parent company of the New York Stock Exchange, according to court papers, Bloomberg reports.

Shares of Abbott Laboratories ( ABT ) are down even as new data showed that an experimental drug from Abbott and Reata Pharmaceuticals reversed declining kidney function in diabetics, the companies said in a statement. The stude showed that bardoxolone bolstered kidney performance by about 30 percent.

Blackboard ( BBBB ) gains after the WSJ reports that it is in exclusive talks with Providence Equity Partners. The acquisition may happen next week, the WSJ said.

Baidu ( BIDU ) says it will make a US$306 million strategic investment in Qunar, which will make BIDU the majority shareholder. The parties currently expect that the transaction will close in Q3.

Pfizer (PFE) and Pain Therapeutics ( PTIE ) shares are lower as the U.S. Food and Drug Administration delayed approval of a new pain killer for the second time. The companies announced that a complete response letter was received from the U.S. Food and Drug Administration on the resubmission to the new drug application for REMOXY (oxycodone) Extended-Release Capsules CII. Pfizer said it is working to evaluate the issues described in the letter and plans to have further discussions with FDA around them.

Bank of Ireland Plc ( IRE ) slips after it says it may raise a total of 2.5 billion euros from its offer to swap subordinated debt for equity or cash, according to Glas Securities, Bloomberg reports.

Commodities are down. August gold contracts are down 0.65% to $1,511 an ounce while August crude oil contacts are down 0.23% to $90.78 a barrel.

In energy ETFs, the United States Oil Fund (USO) is down 1.17% to $35.59 and the United States Natural Gas fund (UNG) is down 0.01%, to $10.70.

In precious metal ETFs, the SPDR Gold Trust (GLD) is down 0.87% at $147.04. Market Vectors Gold Miners (GDX) is down 1.98% to $52.94. iShares Silver Trust (SLV) is down 1.08% to $34.



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


This article appears in: Investing , Commodities

Referenced Stocks: ABT , BBBB , BIDU , IRE , PTIE

MT Newswires

MT Newswires

More from MT Newswires:

Related Videos

Stocks

Referenced

Most Active by Volume

106,677,910
  • $17.03 ▲ 0.47%
101,357,777
  • $38.65 ▼ 5.57%
61,830,117
  • $89.89 ▼ 4.26%
54,116,071
  • $5.11 ▼ 4.49%
50,121,934
  • $101.06 ▲ 0.10%
49,993,927
  • $3.52 ▼ 1.40%
47,717,687
  • $11.44 ▼ 4.67%
44,793,169
  • $99.05 ▼ 0.93%
As of 9/22/2014, 04:15 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com